Home monitoring of patients after prosthetic valve replacement - A new method of early detection of valve dysfunction;Postoperative betreuung von patienten nach alloprothetischem herzklappenersatz - Neue methoden zur risikosenkung sowie früherkennung von prothesendysfunktionen

Zeitschrift fur Kardiologie

Volumn 93, Issue 9, 2004, Pages 664-670

  Fritzsche, Dirk ^a   Eitz, Thomas ^a   Grimmig, Oliver ^a   Horstkotte, Dieter ^a   Körfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Heart valve prostheses; Mechanical heart valves; Oral anticoagulation; Prosthetic valve dysfunction; Prosthetic valve thrombosis; ThromboCheck

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; BLEEDING; EARLY DIAGNOSIS; HEART VALVE PROSTHESIS; HOME MONITORING; HUMAN; INSTRUMENT; INTERNATIONAL STANDARD UNIT; PATIENT MONITORING; POSTOPERATIVE CARE; REVIEW; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

ADMINISTRATION, ORAL; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION TESTS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MONITORING, PHYSIOLOGIC; PROSTHESIS FAILURE; RISK FACTORS; SELF CARE; SWINE; THROMBOSIS; TIME FACTORS;

EID: 4644227209     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0114-0     Document Type: Review

References (11)

1. Takkenberg JJM, Puvimanasinghe JPA, van Herweden LA, Steyerberg EW, Eijkemans MJC, Habbema JDF, Bogers AJJC (2001) Prognosis after aortic valve replacement with St. Jude Medical bileaflet prostheses: impact of the GELIA Database (GELIA 4), Vol 3. Europ Heart J, Suppl Q27-32
2. Huth C, Rost F (2001) Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA Database (GELIA 4), Vol 3. Europ Heart J, Suppl Q33-38
3. Pruefer D, Dahm M, Dohmen G, Horstkotte D, Bergemann R, Oelert H (2001) Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA5). Europ Heart J, Suppl 3:Q39-43
4. Horstkotte D, Burkhardt D (1995) Prosthetic valve thrombosis. J Heart Valve Dis 4:141-153
5. Piper C, Hering D, Horstkotte D (2001) Prosthetic valve thrombosis predisposition and diagnosis. Europ Heart J, Suppl 3:Q16-21
6. Piper C, Horstkotte D (2004) State of the art anticoagulation management. J Heart Valve Dis 13 (in press)
7. Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker S (2004) Antithrombotic Therapy in Valvular Heart Disease: Native and Prosthetic. 7th ACCP Consensus Conference on Antithrombotic Therapy. Chest (in press)
8. Marek G, Niehus R, Schunicht R, Klein RM, Esser G, Horstkotte D (1992) Schallspektrographische Untersuchungen an St. Jude Medical (SJM) und Björk-Shiley Monostrut (BSM) Aortenklappenprothesen. Z Kardiol (Suppl 3):52
9. Niehus R, Bagner J, Klein RM, Schunicht R, Horstkotte D (1994) Vorhersagbarkeit von ron Bügelbrüchen konvex-konkaver Björk-Shiley Mitralklappenprothesen (BScc) durch schallspektroskopische Untersuchungen. Z Kardiol 83(Suppl 1):165
10. Eitz T, Fritzsche D, Grimmig O, Frerichs I, Frerichs A, Hellige G, Minami K, Körfer R (2003) Acoustic Phenomena and Valve Dysfunction in Cardiac Prostheses: Data Acquisition and Collection via the Internet. J Heart Valve Disease 12:414-419
11. Koertke H, Minami K, Boethig D, Breymann T, Seifert D, Wagner O et al (2003) INR Self-Management Permits Lower Anticoagulation Levels after Mechanical Heart Valve Replacement. Circulation 108(Suppl II):II75-78